冠城国际

Crown Castle: Keybanc maintains Overweight, PT down to $115 from $120.

Crown Castle: UBS maintains Buy rating with PT down to $116 from $127.

Goldman Sachs

Goldman Sachs Downgrades Crown Castle to Neutral, PT Cut to $105

Crown Castle

JPMorgan Cuts Crown Castle's PT to $110, Maintains Neutral Rating

Crown Castle's 15min chart shows MACD Death Cross and KDJ Death Cross

Catalyst<ul> <li>Extra-large and small fund flows show positive net inflow trends, indicating institutional confidence in CCI.</li></ul>Risk<ul> <li>Bearish Engulfing candlestick patterns and a MACD Death Cross on January 7, 2026, suggest potential downward pressure.</li> <li>Analyst ratings are split, with three out of four analysts issuing a Neutral rating, indicating uncertainty about CCI's outlook.</li></ul>

Key Factors

Keybanc maintains Overweight rating on CCI with price target lowered to $115 from $120. UBS maintains Buy rating on CCI with price target reduced to $116 from $127. Goldman Sachs downgrades CCI to Neutral with price target cut to $105.

Recent Updates

CCI News